Clinical trial
Safety Study In Patients Who Were Born Small And Short And Were Treated With…
NCT00396474 · Pfizer, Industry · Withdrawn
Key facts
| NCT number | NCT00396474 |
|---|---|
| Title | Safety Study In Patients Who Were Born Small And Short And Were Treated With Growth Hormone To Achieve Normal Height |
| Official title | Long-Term Metabolic Risk In Small for Gestational Age (SGA) Patients After Growth Hormone Treatment Compared To Matched, Untreated Controls |
| Lead sponsor | Pfizer, Industry |
| Status | Withdrawn |
| Study type | Observational |
| Conditions | Infant, Small for Gestational Age |
| Intervention type | Other |
| Interventions | post GH treatment observational study |
| Enrollment | 0 |
| Start date | Jan 1, 2009 |
| Completion | Jan 1, 2012 |
| First posted | Nov 7, 2006 |
| Last update posted | Apr 22, 2015 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: